684
Views
15
CrossRef citations to date
0
Altmetric
Articles

The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey

ORCID Icon, , , , , , ORCID Icon, ORCID Icon, , , , , , , , , , , , , , , , , , , , ORCID Icon & show all
Pages 2137-2144 | Received 16 Mar 2021, Accepted 05 May 2021, Published online: 24 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

María José Valencia López, Brigitte Stephan, Anna Meineke, Sandra Wolf, Diamant Thaci, Ulrich Mrowietz, Valerie Andrees, Stephan Jeff Rustenbach, Kristian Reich, Linus Thalmann, Henriette Bogena, Petra Staubach, Ralph Michael von Kiedrowski & Matthias Augustin. (2024) Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries. Psoriasis: Targets and Therapy 14, pages 29-38.
Read now

Articles from other publishers (14)

Matteo Megna, Giuseppe Lauletta, Nello Tommasino, Antonia Salsano, Teresa Battista, Angelo Ruggiero, Fabrizio Martora & Luca Potestio. (2024) Management of Psoriasis Patients with Serious Infectious Diseases. Advances in Therapy 41:6, pages 2099-2111.
Crossref
Zhihui Yang, Yu Jin, Mingyue Wang, Ruoyu Li, Wen-Qing Li & Hang Li. (2024) Enhanced impact of psoriasis severity on the treatment demands of patients during the COVID-19 pandemic: a cross-sectional study based on a national psoriasis registry in China. BMJ Open 14:2, pages e079627.
Crossref
Janosch Railton, Martina Volonté, Eugenio Isoletta, Alice Bonelli, Stefania Barruscotti & Valeria Brazzelli. (2024) Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine. Frontiers in Immunology 15.
Crossref
Yue Xiao, Xiwen Zhang, Xun Feng, Jingya Gao, Furong Li, Wenyao Mi, Mingqi Wang, Yuanxia Gu, Yiyi Wang, Wen Wang & Wei Li. (2023) The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study. Dermatologic Therapy 2023, pages 1-7.
Crossref
Nazila Ghoreishi Amin, Sepehr Khosravi, Najmolsadat Atefi, Farnoosh Seirafianpour, Sahand Farhoodi & Azadeh Goodarzi. (2023) A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting. Immunity, Inflammation and Disease 11:11.
Crossref
H. Arlegui, E. Mahé, M.-A. Richard, Y. De Rycke, M. Viguier, M. Beylot-Barry, A. Dupuy, N. Beneton, P. Joly, D. Jullien, H. Bachelez, É. Sbidian, O. Chosidow, C. Paul & F. Tubach. (2023) Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Annales de Dermatologie et de Vénéréologie 150:2, pages 101-108.
Crossref
Sophia Quirke-McFarlane, John Weinman, Emma S Cook, Zenas Z N Yiu, Nick Dand, Sinead M Langan, Katie Bechman, Teresa Tsakok, Kayleigh J Mason, Helen McAteer, Freya Meynell, Bolaji Coker, Alexandra Vincent, Dominic Urmston, Amber Vesty, Jade Kelly, Camille Lancelot, Lucy Moorhead, Ines A Barbosa, Herve Bachelez, Francesca Capon, Claudia R Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jo Lambert, Luigi Naldi, Lluís Puig, Phyllis Spuls, Tiago Torres, Richard B Warren, Hoseah Waweru, James B Galloway, Christopher E M Griffiths, Jonathan N Barker, Sam Norton, Catherine H Smith, Satveer K Mahil, Haleema Alfailakawi, Wisam Alwan, Rosa Andres Ejarque, Ines Barbosa, Carmen Bugarin Diz, Katarzyna Grys, Mahira Hamdy El Sayed, Tran Hong Truong, Masanori Okuse, Dagmara Samselska, Isabella Tosi & Ya-Hsin Wang. (2023) Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey. British Journal of Dermatology 188:5, pages 610-617.
Crossref
Elena Olmastroni, Federica Galimberti, Elena Tragni, Alberico L. Catapano & Manuela Casula. (2023) Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review. International Journal of Environmental Research and Public Health 20:5, pages 3825.
Crossref
Meitong Liu, Huijuan Wang, Lu Liu, Saijin Cui, Xiangran Huo, Zhuoyun Xiao, Yaning Zhao, Bin Wang, Guoqiang Zhang & Na Wang. (2022) Risk of COVID-19 infection, hospitalization and mortality in psoriasis patients treated with interleukin-17 inhibitors: A systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Anna Campanati, Federico Diotallevi, Emanuela Martina, Giulia Radi & Annamaria Offidani. (2022) Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. Journal of Clinical Medicine 11:9, pages 2422.
Crossref
P.R. Criado, M. Ianhez, C.C. Silva de Castro, C. Talhari, P.M. Ramos & H.A. Miot. (2021) COVID‐19 and skin diseases: results from a survey of 843 patients with atopic dermatitis, psoriasis, vitiligo and chronic urticaria. Journal of the European Academy of Dermatology and Venereology 36:1.
Crossref
Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, Vana Spoulou, Gkikas Magiorkinis, Ioannis Trontzas, Panagiotis Trontzas, Garyphallia Poulakou, Konstantinos Syrigos & Giorgos Bamias. (2021) Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments. Alimentary Pharmacology & Therapeutics 55:2, pages 154-167.
Crossref
Edward Hadeler, Julie Hong, Megan Mosca, Marwa Hakimi & Tina Bhutani. 2022. Biologic Therapy for Psoriasis. Biologic Therapy for Psoriasis 125 130 .
Elia Rosi, Maria Thais Fastame, Antonella Di Cesare, Gianmarco Silvi, Nicola Pimpinelli & Francesca Prignano. (2021) Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. Journal of Clinical Medicine 10:24, pages 5841.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.